The interest of this is threefold. First, patients with altered states of consciousness continue to represent a major clinical problem in terms of clinical assessment of consciousness and daily management.

Characterization of anatomical structure through segmentation has become essential for morphological assessment and localizing quantitative measures.

This book is designed to be accessible to all scientists and clinicians interested in conducting fMRI neurofeedback research, addressing the variety of different knowledge gaps that readers may have given their varied backgrounds and ...

An important feature of this work is the S-plus subroutines provided for analyzing actual data sets. Coupled with the discussion of new theoretical research, the book should benefit both the researcher and the practitioner.

... neuroimaging 10 : 361 immunohistology 10 : 361 three - dimensional reconstructions 10 : 361 two - dimensional ... 143 enhanced LTP - like effects 1 : 143 , 1 : 145 hyperactivity after 1 : 143 , 1 : 145 restoration of silent cells ...

... Vol 25: 6797-6806 Budinger E, Heil P, Hess A & Scheich H (2006). Multisensory processing via early cortical stages: Connections of the primary auditory cortical field with other sensory systems. Neurosci Vol 143: 1065-1083 Caetano G ...

What goes wrong in the brains of people suffering from emotional disorders? This book reviews modern neuroscientific and psychological research providing answers to these questions.

This book communicates knowledge and research findings in the neurobiological field to those who work with offenders and those who design policy for offender rehabilitation and criminal justice systems, so that practice and policy can be ...

This book discusses the emerging field of industrial neuroscience, and reports on the authors’ cutting-edge findings in the evaluation of mental states, including mental workload, cognitive control and training of personnel involved ...

This is an indispensable ‘how to’ manual of quantitative MR, essential for anyone who wants to use the gamut of modern quantitative methods to measure the effects of neurological disease, its progression, and its response to treatment.